Progressive supranuclear palsy

Progressive supranuclear palsy (PSP) is a rare neurological disorder that is often referred to as Steele-Richardson-Olszewski syndrome. It is a form of Parkinson's disease that is atypical and can be distinguished from other similar diseases, such as multisystem atrophy (MSA), through brain metabolism imaging and dopamine transporter imaging.From: A Novel Approach Using Learning Algorithm for Parkinson’s Disease Detection with Handwritten Sketches’ [2022], Handbook of Nuclear Medicine and Molecular Imaging for Physicists [2022]

Explore chapters and articles related to this topic

Neuroimaging in Nuclear Medicine

View Chapter

Purchase Book

Published in Michael Ljungberg, Handbook of Nuclear Medicine and Molecular Imaging for Physicists, 2022

Anne Larsson Strömvall, Susanna Jakobson Mo

Lewy-body dementia (LDB) is a neurodegenerative disease sharing the features of AD and Parkinson´s disease and may be diagnosed by a combination of metabolic and dopaminergic imaging, as seen in Figure 13.9. Also, in atypical parkinsonian diseases, for example multisystem atrophy (MSA) and progressive supranuclear palsy (PSP), imaging of brain metabolism is used in combination with dopamine transporter imaging to determine the specific type of disease.

A Novel Approach Using Learning Algorithm for Parkinson’s Disease Detection with Handwritten Sketches’

View Article

Journal Information

Published in Cybernetics and Systems, 2022

Anurag Shrivastava, Midhun Chakkaravarthy, Mohd Asif Shah

Progressive supranuclear palsy (PSP), commonly referred to as Steele-Richardson-Olszewski syndrome, is an extremely rare form of Parkinson’s disease. Although PSP is characterized by a more fast advancement of symptoms than idiopathic Parkinson’s disease is, both conditions commonly make their appearance in middle age. PSP is characterized by a more rapid progression of symptoms than idiopathic Parkinson’s disease.